Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary
Robert F. Tamburro(National Institutes of Health), Aruna Natarajan(National Heart Lung and Blood Institute), Nahed El-Kassar(National Heart Lung and Blood Institute), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Ashok Srinivasan(St. Jude Children's Research Hospital), Samuel Goldfarb(Children's Hospital of Philadelphia), Kenneth R. Cooke(Johns Hopkins University), Nonniekaye Shelburne(National Cancer Institute), Dennis C. Stokes(Children's Hospital at Dartmouth Hitchcock), Nancy DiFronzo(National Heart Lung and Blood Institute), Marie E. Steiner(Boston University), James S. Hagood(University of North Carolina at Chapel Hill)
Cited by 56
Related Papers
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery
|New England Journal of Medicine|2015|489
Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis
|The Journal of Pediatrics|2007|441
A biomarker panel for acute graft-versus-host disease
|Blood|2008|404
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363